Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Decreased levels of EGF in plasma of children with autism spectrum disorder.

Onore C, Van de Water J, Ashwood P.

Autism Res Treat. 2012;2012:205362. doi: 10.1155/2012/205362. Epub 2012 Mar 5.

2.

Anti-inflammatory effects of epidermal growth factor on the immature human intestine.

Ménard D, Tremblay E, Ferretti E, Babakissa C, Perron N, Seidman EG, Levy E, Beaulieu JF.

Physiol Genomics. 2012 Feb 27;44(4):268-80. doi: 10.1152/physiolgenomics.00101.2011. Epub 2012 Jan 3.

3.

The role of inflammation in epilepsy.

Vezzani A, French J, Bartfai T, Baram TZ.

Nat Rev Neurol. 2011 Jan;7(1):31-40. doi: 10.1038/nrneurol.2010.178. Epub 2010 Dec 7. Review.

4.

The role of neurotrophic factors in autism.

Nickl-Jockschat T, Michel TM.

Mol Psychiatry. 2011 May;16(5):478-90. doi: 10.1038/mp.2010.103. Epub 2010 Oct 12. Review.

PMID:
20938434
5.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J.

Brain Behav Immun. 2011 Jan;25(1):40-5. doi: 10.1016/j.bbi.2010.08.003. Epub 2010 Aug 10.

6.

Increased serum levels of epidermal growth factor in children with autism.

Işeri E, Güney E, Ceylan MF, Yücel A, Aral A, Bodur S, Sener S.

J Autism Dev Disord. 2011 Feb;41(2):237-41. doi: 10.1007/s10803-010-1046-3.

PMID:
20544265
7.

Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.

Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, Bianchi ME, Vezzani A.

Nat Med. 2010 Apr;16(4):413-9. doi: 10.1038/nm.2127. Epub 2010 Mar 28.

PMID:
20348922
8.

Inhibitory role for GABA in autoimmune inflammation.

Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsien RW, Steinman L.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2580-5. doi: 10.1073/pnas.0915139107. Epub 2010 Feb 1.

9.

Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease.

Russo AJ, Krigsman A, Jepson B, Wakefield A.

Biomark Insights. 2009 Nov 27;4:181-90.

10.

Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors.

Rauvala H, Rouhiainen A.

Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):164-70. doi: 10.1016/j.bbagrm.2009.11.012. Epub 2009 Nov 13. Review.

PMID:
19914413
11.

Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.

Bae MH, Bissonette GB, Mars WM, Michalopoulos GK, Achim CL, Depireux DA, Powell EM.

Exp Neurol. 2010 Jan;221(1):129-35. doi: 10.1016/j.expneurol.2009.10.011. Epub 2009 Oct 22.

12.

Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Enstrom AM, Onore CE, Van de Water JA, Ashwood P.

Brain Behav Immun. 2010 Jan;24(1):64-71. doi: 10.1016/j.bbi.2009.08.001. Epub 2009 Aug 8.

13.

Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin.

Pastore S, Mascia F.

Expert Rev Dermatol. 2008 Oct;3(5):525-527. No abstract available.

14.

HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism.

Oh YJ, Youn JH, Ji Y, Lee SE, Lim KJ, Choi JE, Shin JS.

J Immunol. 2009 May 1;182(9):5800-9. doi: 10.4049/jimmunol.0801873.

15.

Elevated immune response in the brain of autistic patients.

Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M.

J Neuroimmunol. 2009 Feb 15;207(1-2):111-6. doi: 10.1016/j.jneuroim.2008.12.002. Epub 2009 Jan 20.

16.

Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex.

Petilla Interneuron Nomenclature Group, Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A, Buzsáki G, Cauli B, Defelipe J, Fairén A, Feldmeyer D, Fishell G, Fregnac Y, Freund TF, Gardner D, Gardner EP, Goldberg JH, Helmstaedter M, Hestrin S, Karube F, Kisvárday ZF, Lambolez B, Lewis DA, Marin O, Markram H, Muñoz A, Packer A, Petersen CC, Rockland KS, Rossier J, Rudy B, Somogyi P, Staiger JF, Tamas G, Thomson AM, Toledo-Rodriguez M, Wang Y, West DC, Yuste R.

Nat Rev Neurosci. 2008 Jul;9(7):557-68. doi: 10.1038/nrn2402. Review.

18.

SNP analyses of growth factor genes EGF, TGFbeta-1, and HGF reveal haplotypic association of EGF with autism.

Toyoda T, Nakamura K, Yamada K, Thanseem I, Anitha A, Suda S, Tsujii M, Iwayama Y, Hattori E, Toyota T, Miyachi T, Iwata Y, Suzuki K, Matsuzaki H, Kawai M, Sekine Y, Tsuchiya K, Sugihara G, Ouchi Y, Sugiyama T, Takei N, Yoshikawa T, Mori N.

Biochem Biophys Res Commun. 2007 Sep 7;360(4):715-20. Epub 2007 Jun 18.

PMID:
17626784
19.

Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism.

Suzuki K, Hashimoto K, Iwata Y, Nakamura K, Tsujii M, Tsuchiya KJ, Sekine Y, Suda S, Sugihara G, Matsuzaki H, Sugiyama T, Kawai M, Minabe Y, Takei N, Mori N.

Biol Psychiatry. 2007 Aug 1;62(3):267-9. Epub 2006 Nov 21.

PMID:
17123472
20.

A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function.

Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K, Miyazaki J, Nakamura T, Yamamoto K.

J Immunol. 2005 Oct 1;175(7):4745-53.

Items per page

Supplemental Content

Write to the Help Desk